Open Nav

Please submit your session questions in advance at

Mark Moore


  • Industry:Gene Therapy
  • Interests:Skiing, running,wine collecting

Mark is an entrepreneurial scientist and an experienced biotech business executive. He is an expert in Molecular Biology and Genetics applied to complex organisms and is the founding CEO of a new gene editing company, LifeEDIT, a spinoff of AgBiome. Mark began his career at Genentech where he was involved in the early discovery projects for Herceptin and Avastin. He was a Founder and CSO of Deltagen, an early stage discovery company in mammalian genomics, which went public in 2000 with over 200 employees. He served recently as Executive Director of the IMPC and Senior Consultant to the National Human Genome Research Institute.

Mark was also Co-Founder and CEO of Glialogix, a company that developed a pharmaceutical agent to a novel target involved in Neurodegeneration.

Mark received his Ph.D. in Biology at Brandeis University and an A.B. from Princeton in Biochemical Sciences.

This speaker's sessions:

  • LifeEDIT
  • Monday, February 11
  • 10:45 AM - 11:00 AM